memo - Magazine of European Medical Oncology

Revival of anti-angiogenic therapies in cancer

• Onkologie
• editorial

Andreas Pircher

Uro-oncology 2018: new horizons, new treatment options, improved patient outcomes

• Onkologie
• editorial

Ursula M. Vogl

In need of special care: adolescent and young adult patients with cancer

• editorial

Michael N. Dworzak

memo—publisher’s report 2017

• editorial

Alois Sillaber

Targeting angiogenesis in lung cancer

• short review

Sameh Daher, Jair Bar

Anti-angiogenic therapies in brain metastases

• Open Access
• short review

Anna S. Berghoff, Matthias Preusser

Antiangiogenic therapies in ovarian cancer

• short review

Adriaan Vanderstichele, Siel Olbrecht, Ignace Vergote

My burning issues in the neoadjuvant treatment for breast cancer

• Open Access
• review

Elisabeth S. Bergen, Rupert Bartsch

My burning issues in TKI therapy and treatment-free remission in CML

• editorial

Dominik Wolf

Practice-changing developments in early use of chemohormonal therapy in metastatic prostate cancer

• short review

Peter Horak

Local therapy of stage IV renal cell cancer: a case report

• case report

Muna Ferner, Andrea Vera Keck, Dora Niedersüß-Beke, Kathrin Strasser-Weippl

PD-1 and PD-L1 inhibitors after platinum-based chemotherapy or in first-line therapy in cisplatin-ineligible patients

• Open Access
• short review

Irene Resch, Shahrokh F. Shariat, Kilian M. Gust

Adolescents and young adults with acute lymphoblastic leukemia and acute myeloid leukemia

• review

Mirella Ampatzidou, Charikleia Kelaidi, Michael N. Dworzak, Sophia Polychronopoulou

Novel guidelines on surveillance for breast cancer, cardiomyopathy, male gonadotoxicity, and premature ovarian insufficiency from the PanCare and International Guideline Harmonization Group on long-term follow-up after cancer in childhood

• review

Edit Bardi, Leo Kager

Short overview on the current standard of treatment in newly diagnosed multiple myeloma

• Open Access
• short review

Ella Willenbacher, Agnes Balog, Wolfgang Willenbacher

Cell free nucleic acids as diagnostic and prognostic marker in leukemia

• review

Maryam Eini, Seyed Ali Nojoumi, Mohammad-Amin Saki, Abbas Khosravi

Pleural effusion in 11:14 translocation q1 multiple myeloma in the setting of proteasome inhibitor presents therapeutic complexity

• Open Access
• case report

Malik Ghannam, Maria Bryan, Erik Kuross, Brent Berry

ESMO 2017—my personal highlights

• Open Access
• comment

Barbara Kiesewetter, Mircea Dediu, Rupert Bartsch

Correction to: Report from the WCLC 2017 Congress, Yokohama, 15th–18th October, 2017

• Publisher Correction